SJM urges PM Modi to revoke Gilead Sciences' patent on COVID-19 drug remdesivir to make it more affordable

Source :: PharmaBiz. October 9, 2020
Publication Year :: 2020
Abstract: Byline: Laxmi Yadav Close on the heels of submission of joint proposal by India and South Africa at World Trade Organization (WTO) seeking waiver of IP rights and patents under [...]

Subjects :: Gilead Sciences Inc. -- Intellectual property -- Licensing agreements
Remdesivir -- Economic aspects
Patents -- Economic aspects
Prime ministers -- Economic aspects
COVID-19 -- Economic aspects
Biological products industry -- Intellectual property -- Licensing agreements
Patent law -- Economic aspects
Patent/copyright issue
Company licensing agreement
Pharmaceuticals and cosmetics industries
World Trade Organization -- Intellectual property

Tools